Tradestie Institutional Equity Comparison Engine

DNTH vs RAPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DNTH Overall Edge

DNTH Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dianthus Therapeutics, Inc. Common Stock (DNTH) driven by superior Growth & Margin, Options & Structure while RAPT counters with relative strength in Momentum & Technical. Fundamentally, DNTH trades at N/M Forward P/E with -8683.9% operating margin (+205.6% YoY revenue) versus RAPT at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, DNTH sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro) against RAPT sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
DNTH N/M vs RAPT N/M Fwd P/E
Growth & Margin Winner DNTH
Op Margin -8683.9% vs 0.0% ยท YoY +205.6% vs -100.0%
Momentum & Technical Winner RAPT
1Y +150.0% vs +480.2% ยท 52W Pos 65% vs 100%
Options & Structure Winner DNTH
CONSOLIDATION (7th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
DNTH NASDAQ
Dianthus Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$88.75
-3.33% 1D
Market Cap $5.2B
1M Return +23.12%
1Y Return +150.01%
Forward P/E N/M
Unified AI Score
34.1 / 100 SELL
Tech 8.0 Fund 43.0 Flow 68.0 Mom 64.0
RAPT NASDAQ
RAPT Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$58.02
+0.07% 1D
Market Cap $1.7B
1M Return +0.68%
1Y Return +480.2%
Forward P/E N/M
Unified AI Score
52.4 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 61.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DNTH +150.01% RAPT +480.2% Spread: +66.67 pp (RAPT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DNTH TTM Op. Margin: -8683.9% RAPT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DNTH vs RAPT. Trailing 12-month operating profitability (DNTH -8683.9% vs RAPT 0.0%) and valuation multiples (DNTH N/M vs RAPT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DNTH (3) vs RAPT (4)
Institutional Metric DNTH RAPT Criterion Row Winner
Market Capitalization Scale $5.2B $1.7B Larger Scale DNTH
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +205.6% -100.0% Higher Growth DNTH
Operating Margin (TTM) Profitability -8683.9% 0.0% Higher Margin RAPT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -22.6% -85.4% Higher ROE DNTH
52-Week Range Position Momentum 65% ($34โ€“$118) 100% ($1โ€“$58) Stronger Trend RAPT
Beta / 30D Volatility Risk Regime 1.04ฮฒ ยท 41% Vol -0.02ฮฒ ยท 2% Vol Lower Realized Risk RAPT
Unified Institutional Score Composite Signal 34.1 / 100 (SELL) 52.4 / 100 (HOLD) Higher Composite RAPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DNTH vs RAPT Buy Guide
DNTH CONSOLIDATION
149d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live DNTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RAPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RAPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DNTH nor RAPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.